Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
186 studies found for:    Open Studies | "Cystic Fibrosis"
Show Display Options
Rank Status Study
1 Recruiting Integrating Supportive Care in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Behavioral: Supportive Care Intervention
2 Not yet recruiting Registry Study on Cystic Fibrosis in Chinese Children
Condition: Cystic Fibrosis
Intervention:
3 Recruiting Observational Study of Outcomes in Cystic Fibrosis Patients With Selected Gating Mutations on a CFTR Allele (The VOCAL Study)
Condition: Cystic Fibrosis
Intervention: Drug: ivacaftor
4 Recruiting Evaluating High Flow Humidification Therapy in Patients With Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Device: High-Flow, 20 LPM (via Optiflow cannula);   Device: Low FLow, 5 LPM (via Optiflow cannula)
5 Recruiting Impaired Secretory IgA and Mucosal Immunity in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Other: Lung explants;   Other: Sputum, nasal fluid and serum;   Procedure: Bronchoscopy
6 Recruiting 6 Minute Walk Test in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Other: 6-minute walk test
7 Recruiting Puberty in Girls Followed for Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Procedure: Data collection
8 Recruiting Studying Patients With Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders
Condition: Cystic Fibrosis
Intervention:
9 Not yet recruiting Aztreonam Aerosol to Treat Cystic Fibrosis Nasal Disease
Condition: Cystic Fibrosis
Interventions: Drug: Oral Aztreonam;   Drug: Nasal Aztreonam;   Drug: Nasal Placebo
10 Recruiting Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified
Condition: Cystic Fibrosis
Interventions: Drug: Ceftazidime;   Drug: Tobramycin
11 Recruiting Kinetics of YKL-40 Protein in Serum of Cystic Fibrosis Patients
Condition: Cystic Fibrosis
Intervention:
12 Not yet recruiting Glycerol Phenylbutyrate Corrector Therapy For CF (Cystic Fibrosis)
Condition: Cystic Fibrosis
Interventions: Drug: Ravicti low dose;   Drug: Ravicti high dose;   Drug: Placebo
13 Recruiting A Phase 2 IV Gallium Study for Patients With Cystic Fibrosis (IGNITE Study)
Condition: Cystic Fibrosis
Interventions: Drug: Gallium nitrate;   Drug: Normal Saline
14 Recruiting Continuous Glucose Monitoring in Controls With and Without Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention:
15 Recruiting Gender Disparity and Hormones in Cystic Fibrosis
Condition: Cystic Fibrosis (CF)
Intervention: Drug: Loestrin (norethindrone acetate and ethinyl estradiol)
16 Recruiting Comparison of Non-invasive Measurement Methods of Hepatic Fibrosis in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Other: Measure of hepatic elasticity
17 Recruiting Transition From Pediatric to Adult Cystic Fibrosis Care Center
Condition: Cystic Fibrosis
Intervention: Other: Transition pediatric - adult
18 Recruiting Metabolic Efficiency of Combined Pancreatic Islet and Lung Transplant for the Treatment of End-Stage Cystic Fibrosis
Conditions: Cystic Fibrosis;   Diabetes Related Cystic Fibrosis
Intervention: Procedure: Combined pancreatic islet and lung transplantation
19 Recruiting Blood Flow and Vascular Function in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: Acute (1 hour) Sildenafil;   Drug: Sub-Chronic (4 weeks) Sildenafil;   Drug: Placebo
20 Recruiting Assessment of Cystic Fibrosis Lung Involvement With UTE Pulse Sequences
Condition: Cystic Fibrosis
Interventions: Device: MR measurements of lung morphological changes in cystic fibrosis (Avanto dot, Siemens);   Device: CT measurements of lung morphological changes in cystic fibrosis

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.